reports
Carlsberg AS: 1 director
A director at Carlsberg AS bought 499 shares at 944.575DKK and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Alliance Trust PLC - Net Asset Value
Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC At the close of business Wednesday 01 May 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was - excluding income, 1237.1p - including income, 1242.7p The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was - excluding income, 1242.3p - including income, 1247.9p For further information, please contact: - Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated in ...
Avance Gas Holding Ltd: Invitation to Earnings Presentation for the Fi...
Avance Gas Holding Ltd: Invitation to Earnings Presentation for the First Quarter of 2024 Bermuda, May 2, 2024, Avance Gas Holding Ltd. (ticker "AGAS") will on Wednesday May 15, 2024, release its unaudited results for the first quarter of 2024. In connection with the earnings release, an audio webcast and conference call will be held at 14:00 (CEST). The presentation and webcast link will be available from the Investor Relation section at Avance Gas' website prior the presentation and available by using the following links: Webcast: -server.com/mmc/p/qwb4tssb Conference call: /regis...
Preferred Bank (Los Angeles, CA): 2 directors
A director at Preferred Bank (Los Angeles, CA) sold 900 shares at 78.080USD and the significance rating of the trade was 38/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
CoreCard Corporation Reports First Quarter 2024 Results
CoreCard Corporation Reports First Quarter 2024 Results NORCROSS, Ga., May 02, 2024 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD) (“CoreCard” or the “Company”), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, announced today its financial results for the quarter ended March 31, 2024. "Overall revenue of $13.1 million in the first quarter was in-line with our expectations, reflecting continued year-over-year growth in processing and maintenance of 13%, which was offset by lower professional ser...
- FIMA Research
Fima Daily Insight 02 May 2024
Please find enclosed our daily market report.Market CommentCroatia AD Plastik boosts net profit in Q1 Podravka Q1 net profit surges 48% YoY Hrvatski Telekom’s Q1 net profit down 1.7% SPAN plans to pay EUR 0.30 share dividend (DIVY 0.7%) Croatia's retail sales volume up real 8.9% in March Slovenia Slovenia's annual inflation rate down 0.6 p.p. in April to 3% Romania Transport Trade Services shareholders approve distribution of RON 68.4 mil as dividends Bulgaria Speedy nea...
Context Therapeutics Announces FDA Clearance of IND Application for a ...
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 CTIM-76 Phase 1 clinical trial to focus on CLDN6-positive gynecologic and testicular cancers Company expects to enroll first patient in mid-2024 PHILADELPHIA, May 02, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that the U.S. Food and Drug Administration (“FDA”) has cleared its Investigational New Drug (“IND”) application for CTIM-76, a Claudin 6 (“CLDN6...
Parker Reports Fiscal 2024 Third Quarter Results
Parker Reports Fiscal 2024 Third Quarter Results Sales were a record at $5.07 billion; organic sales increased 1%Segment operating margin was 21.5%, or a record 24.7% adjusted, an increase of 150 basis pointsEPS were $5.56, or a record $6.51 adjusted, an increase of 10%Company increases outlook for segment operating margin and EPS2024 Investor Meeting scheduled for May 16 at 2 p.m. Eastern time CLEVELAND, May 02, 2024 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the fiscal 2024 third quarter e...
Map Aktif Adiperkasa Tbk PT: 1 director
A director at Map Aktif Adiperkasa Tbk PT bought 3,700,000 shares at 800.000IDR and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Capricorn Metals Ltd: 1 director
A director at Capricorn Metals Ltd sold 2,011,539 shares at 4.900AUD and the significance rating of the trade was 85/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Oma Säästöpankki Oyj: Johdon liiketoimet – Jarmo Salmi
Oma Säästöpankki Oyj: Johdon liiketoimet – Jarmo Salmi OMA SÄÄSTÖPANKKI OYJ, PÖRSSITIEDOTE 2.5.2024 KLO 14.30, JOHTOHENKILÖIDEN LIIKETOIMET Oma Säästöpankki Oyj: Johdon liiketoimet – Jarmo Salmi Ilmoitusvelvollinen: Nimi: Jarmo Salmi Asema: Hallituksen jäsen/varajäsen Liikkeeseenlaskija: Oma Säästöpankki OyjLEI: 743700LE1ECAPXC5UT18Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 60910/5/4Liiketoimen päivämäärä: 2.5.2024Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Liiketoimen luonne: HANKINTAInstrumenttityyppi: OSAKEISIN: FI4000306733 Liiketoimien yksityiskohtaiset tiedot(1): Volyymi:...
Altimmune to Report First Quarter 2024 Financial Results and Provide B...
Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 GAITHERSBURG, Md., May 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 and will provide a business update. Altimmune management will host a conference call at 8:30 am E.T. on May 9 to discuss financial results and provide a business update. The conference call will be webcast live on Altimmune’s Investor Relations website at . Participants who woul...
AppTech Payments Corp. to Present at Sidoti Virtual Investor Conferenc...
AppTech Payments Corp. to Present at Sidoti Virtual Investor Conference May 8-9 CARLSBAD, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce, announced Luke D’Angelo, Chairman & CEO, will present and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, taking place on May 8-9, 2024. The presentation will begin at 4 PM ET on May 8, 2024 and can be accessed live here: . AppTech will also host virtual one-on-ones with investors on Wednesday and Thursday, May 8-9, 2024...
Avis de conférence téléphonique de Thérapeutique Knight sur ses résult...
Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du premier trimestre 2024 MONTRÉAL, 02 mai 2024 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (ex. EU) et chef de file, publiera ses résultats financiers du premier trimestre 2024, ce jeudi 9 mai 2024 avant l’ouverture du marché. À la suite de cette publication, Knight sera l’hôte d’une conférence téléphonique et d’une webémission. Knight invite cordialement toutes les parties intéressées à participer à cet appel. Date : Jeudi 9 mai 2024 He...
FuelCell Energy and Toyota Motor North America Celebrate Launch of Wor...
FuelCell Energy and Toyota Motor North America Celebrate Launch of World's First "Tri-gen" Production System at the Port of Long Beach FuelCell Energy’s Tri-gen technology produces three products: renewable electricity, renewable hydrogen, and usable waterMarks Toyota’s first port vehicle processing facility in the world to be powered by onsite-generated, 100 percent renewable electricityBoth light-duty and Class 8 heavy-duty fuel cell electric vehicles have been fueled using Tri-gen generated renewable hydrogen LONG BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: FCEL) and Toy...
Stack Capital Group Inc. Reports Q1-24 Financial Results
Stack Capital Group Inc. Reports Q1-24 Financial Results TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (“Stack Capital” or the “Company”) (TSX: STCK and STCK.WT) today announced its financial results for the quarter ended March 31, 2024. Stack Capital reports all amounts in Canadian Dollars unless otherwise stated. Company Commentary: As at March 31, 2024, Book Value per Share (BVpS) of the Company was $11.03, compared with $10.91 as at December 31, 2023.Stack Capital increased its exposure to Locus Robotics through a share-swap transaction issuing 273,501 Stack Ca...
Arbutus Reports First Quarter 2024 Financial Results and Provides Corp...
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001 clinical trial show that AB-101 was generally well-tolerated and bound to the receptor target in healthy subjects Court provides claim construction ruling in ongoing patent infringement lawsuit against Moderna; Court date scheduled for April 21, 2025 Strong financial position – expected cash runway extended throu...
GURU Organic Energy Enters Zero Sugar Segment With Metabolism-Boosting...
GURU Organic Energy Enters Zero Sugar Segment With Metabolism-Boosting GURU Zero Wild Berry ZERO SUGAR: fastest growing energy drink segment in Quebec1 and the US2 as more consumers seek low-calorie, sugar-free energy drinks.METABOLISM BOOST: EGCG and catechins, a form of green tea polyphenols, are clinically studied for their potent antioxidant effects and metabolism boosting when combined with caffeine. This metabolism boost helps burn more calories and convert energy faster to support active lifestyles and improved physical performance.Initial launch in retail stores in Quebec and online...
Volt Lithium Announces Closing of US$1.5 Million Strategic Investment
Volt Lithium Announces Closing of US$1.5 Million Strategic Investment Not for distribution to United States newswire services or for dissemination in the United States. CALGARY, Alberta, May 02, 2024 (GLOBE NEWSWIRE) -- Volt Lithium Corp. (TSXV: VLT | OTCQB: VLTLF) (“Volt” or the “Company”) is pleased to announce that it has closed its previously announced non-brokered private placement of 6,818,182 units of Volt (“Units”) issued to a strategic investor (the “Investor”) at a price of US$0.22 per Unit for aggregate consideration of US$1,500,000 (the “Strategic Investment”) effective May...
GURU Organic Energy fait son entrée dans le segment sans sucre avec GU...
GURU Organic Energy fait son entrée dans le segment sans sucre avec GURU Zéro Baies sauvages qui boost le métabolisme ZÉRO SUCRE : le segment des boissons énergisantes qui connaît la plus forte croissance au Québec1 et aux États-Unis2, alors que plus de consommateurs recherchent des boissons énergisantes à faible teneur en calories et sans sucre.BOOST LE MÉTABOLISME : l'EGCG et les catéchines, une forme de polyphénols du thé vert, ont fait l'objet d'études cliniques pour leurs puissants effets antioxydants et leur capacité à accélérer les fonctions métaboliques lorsqu'ils sont associés à la...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.